You searched for "neuroretinopathy"
BARS (British Association of Retinal Screening) Conference 2023
28 September 2023
-29 September 2023
Why not join us at the BARS Conference 2023 in the vibrant city of Bristol, at the Marriott Hotel on Thursday 28 and Friday 29 September. This year there is something for everyone with an interest in diabetic eye screening....
Changing surgery trends from 2009–2020
This paper reports a review of the number and type of surgeries over one decade in a Portuguese hospital. This was a retrospective review of 2050 surgeries. About 70% were strabismus surgery and the remainder included anterior segment and retinopathy...In conversation with Dr Hazel Shillingford-Ricketts
25 May 2022
| Hazel Shillingford-Ricketts
We spoke to Dr Hazel Shillingford-Ricketts about the work of Vision 2020 LINKS and treatments in diabetic retinopathy.
Development of eyecare services in Dominica: Past, present, and future
3 October 2024
| Hazel Shillingford-Ricketts, Kevin Melanson, Marcia Zondervan, Covadonga Bascaran
|
EYE - General
Dominica is a small island developing state in the Caribbean with a population of approximately 73,000 people [1] and has a long and proud history of developing eyecare services through international partnerships. This article will give you an outline of...
Screening for Sickle Cell Retinopathy (SCR): Why we do wide-field imaging, OCT/OCT-A for SCR – Newcastle upon Tyne Hospitals NHS Foundation Trust
I have been working in ophthalmology for over five years as a photographer and research co-ordinator, and it is fascinating, rewarding, and interesting to learn all about the different diseases associated with the eye. One condition that has been a...
IAC vs. IVC chemotherapy for RB
This a single centre retrospective review of consecutive patients between 1997 and 2014, of all sporadic unilateral retinoblastoma (RB) group D cases, treated with combined intravenous chemotherapy (IVC) and focal treatments (1997- 2008), or intra-arterial chemotherapy (IAC) treatment (2008 to...
Aflibercept, bevacizumab or ranibizumab for diabetic macular oedema
1 April 2015
| Jonathan CP Roos
|
EYE - Vitreo-Retinal
Macular oedema (MO) is a leading cause of visual impairment in patients with diabetic retinopathy. Whilst laser photocoagulation therapy has been the proven treatment for decades, studies over the last five years have also established a role for anti-VEGF agents...
Intensive diabetes therapy and ocular surgery in type 1 diabetes
1 October 2015
| Jonathan CP Roos
|
EYE - Vitreo-Retinal
The Diabetes Control and Complications Trial (DCCT) ran between 1983 and 1993 and showed that intensive glycaemic control was beneficial in reducing diabetic retinopathy in type 1 patients. There was a 76% reduction in onset of retinopathy and a 52%...
Inner nuclear layer of the retina showing increase in thickness in diabetic macular oedema
1 October 2015
| Bheemanagouda Patil
|
EYE - Vitreo-Retinal
Diabetic retinopathy is one of the leading causes of blindness in the developed world. With optical coherence tomography (OCT), it has become possible to image the retina in vivo and to measure retinal oedema by measuring retinal thickness (RT) with...
Assessing failure of laser coagulation treatment for type 1 retinopathy of prematurity
7 April 2021
| Kareem Waleed Alsaffarini
|
EYE - Vitreo-Retinal
The authors present the findings of a retrospective study to examine the cause of treatment failures in type 1 retinopathy of prematurity (ROP). They reviewed the medical charts of all infants with persistent disease post laser treatment at Uppsala University...
